|
Angela Stoyanovitch Vice President, Business Development Ms. Stoyanovitch is a business development veteran with 19 years of R&D experience and 10 years of success in direct-sales roles at Contract Research Organization (CROs) including Charles River Laboratories, Southern Research, and BioAgilytix. She has matched academic, government, biotech and pharma sponsors with CRO services in a wide variety of therapeutic areas and on numerous technology platforms. She has worked with both small and large molecules with vastly different drug modalities. Ms. Stoyanovitch has supported clients seeking to outsource preclinical, bioanalytical, clinical, and manufacturing services, in early drug discovery and drug development, in accordance with a broad set of regulatory guidelines including GxP standards. Ms. Stoyanovitch received her Bachelor's degree in Biology, with Neuroscience and Religion minors, from Hope College. She started and hosted Legal Drugs Podcast, educating the drug development industry and the general public to encourage safer, faster, and more effective drugs to market. As a speaker and panelist, she highlights innovation through motivational storytelling about the ambitious efforts of biomedical research. |